Phase III clinical study for Tasimelteon in delayed sleep phase disorder (DSPD)
Latest Information Update: 17 Feb 2021
At a glance
- Drugs Tasimelteon (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Adverse reactions; Therapeutic Use
- 17 Feb 2021 New trial record
- 10 Feb 2021 According to Vanda pharmaceutical this study is expected to be initiated in the first quarter of 2021.